// Press Release
Regulation of Vaping Products Should Protect Youth, Help Adult Smokers Switch
Regulation of Vaping Products Should Protect Youth, Help Adult Smokers Switch TORONTO, Sept. 4, 2019 /CNW/ – Vaping products should be regulated to protect youth from nicotine addiction and help adult smokers switch away from cigarettes, Rothmans, Benson & Hedges Inc. said in a submission today to Health Canada. RBH’s recommendations were submitted to Health … Continue reading Regulation of Vaping Products Should Protect Youth, Help Adult Smokers Switch
New guideline clarifies role of radiation therapy in pancreatic cancer treatment
New guideline clarifies role of radiation therapy in pancreatic cancer treatment First-of-its-kind clinical guideline from leading radiation oncology society discusses radiation dosing, conventional versus stereotactic radiation and mitigating side effects A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy to treat patients diagnosed with pancreatic cancer, … Continue reading New guideline clarifies role of radiation therapy in pancreatic cancer treatment
Find time for fitness this STRESS-tember
Find time for fitness this STRESS-tember There’s a reason it’s known as STRESS-tember. You have too much to do at work, at home, and in your social life and healthy habits take a back seat because you’re just ‘too busy.’ The reality is Canadians are fitting more activities than ever into their days. In a national survey of … Continue reading Find time for fitness this STRESS-tember
ETNA-AF Registry Data Provide Real-world Evidence of the Efficacy and Safety Profile of LIXIANA® (edoxaban) in Elderly Non-Valvular Atrial Fibrillation Patients
ETNA-AF Registry Data Provide Real-world Evidence of the Efficacy and Safety Profile of LIXIANA® (edoxaban) in Elderly Non-Valvular Atrial Fibrillation Patients MONTREAL, Sept. 4, 2019 /CNW Telbec/ – Servier Canada announces one-year outcomes results from a study of 24,962 patients with non-valvular atrial fibrillation (NVAF) treated with LIXIANA® (Edoxaban), including elderly NVAF patients and those with … Continue reading ETNA-AF Registry Data Provide Real-world Evidence of the Efficacy and Safety Profile of LIXIANA® (edoxaban) in Elderly Non-Valvular Atrial Fibrillation Patients
Crohn’s and Colitis Canada Announces Updated Position Statement on Biosimilar Drugs
Crohn’s and Colitis Canada Announces Updated Position Statement on Biosimilar Drugs TORONTO, Sept. 5, 2019 /CNW/ – Today, Crohn’s and Colitis Canada released their updated Position on biosimilar drugs. Supporting studies, including a report on cross-Canada surveys of patients and caregivers, gastroenterologists and inflammatory bowel disease (IBD) nurses was also released. “Crohn’s and Colitis Canada is a research-based … Continue reading Crohn’s and Colitis Canada Announces Updated Position Statement on Biosimilar Drugs
How Common are Mental Health Problems in Arthritis Patients? Research Reveals Flaw in Determining Extent of Problem
How Common are Mental Health Problems in Arthritis Patients? Research Reveals Flaw in Determining Extent of Problem VANCOUVER, Sept. 5, 2019 /CNW/ – A recent Arthritis Research Canada study has revealed that while administrative health databases are increasingly being used to study mental health in rheumatic diseases, researchers have used different ways to identify patients who … Continue reading How Common are Mental Health Problems in Arthritis Patients? Research Reveals Flaw in Determining Extent of Problem
Fighting frostbite: focusing on prevention and early drug treatment are the keys to success
Fighting frostbite: focusing on prevention and early drug treatment are the keys to success The Physiological Society – Press release For immediate release – 3 September 2019 Frostbite is an injury which usually affects the extremities, such as fingers and toes, and has the potential of causing irreversible tissue loss. The treatment of freezing cold … Continue reading Fighting frostbite: focusing on prevention and early drug treatment are the keys to success
ProMIS Neurosciences to Present at HC Wainwright Investment Conference
ProMIS Neurosciences to Present at HC Wainwright Investment Conference Company to showcase its innovative Alzheimer’s, Parkinson’s and ALS programs TORONTO and CAMBRIDGE, MA, Sept. 3, 2019 /CNW/ – ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative … Continue reading ProMIS Neurosciences to Present at HC Wainwright Investment Conference
Servier Canada announces Positive Results of the ENTRUST-AF PCI Study of LIXIANA® (edoxaban) in Patients with Atrial Fibrillation
Servier Canada announces Positive Results of the ENTRUST-AF PCI Study of LIXIANA® (edoxaban) in Patients with Atrial Fibrillation ENTRUST-AF PCI study achieved the primary safety endpoint of non-inferiority in bleeding for edoxaban-based dual therapy compared with VKA-based triple antithrombotic therapy (using a risk-based duration of ASA for at least one month) in AF patients following … Continue reading Servier Canada announces Positive Results of the ENTRUST-AF PCI Study of LIXIANA® (edoxaban) in Patients with Atrial Fibrillation
Human Flourishing in an Age of Gene Editing
Human Flourishing in an Age of Gene EditingNew book edited by Hastings Center scholars explores fundamental questions about the nature and well-being of human beings at a time when a revolutionary new biotechnology could permanently change the human species International uproar followed the recent birth of the first babies created from embryos whose genomes … Continue reading Human Flourishing in an Age of Gene Editing
